Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Blueprint_Medicines_Corporation
|
| gptkbp:activities |
inhibitor of fibroblast growth factor receptors
|
| gptkbp:developed_by |
gptkb:Blueprint_Medicines_Corporation
|
| https://www.w3.org/2000/01/rdf-schema#label |
BLU-782
|
| gptkbp:ingredients |
C22 H24 N4 O3 S
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:is_used_for |
treatment of cancer
|
| gptkbp:related_to |
FGFR inhibitors
|
| gptkbp:status |
investigational drug
|
| gptkbp:targets |
FGF R2
|
| gptkbp:type_of |
1234567-89-0
|